Who Owns GoodRx?

What does GoodRx own?
GoodRx owns a portfolio of digital healthcare brands and services. These include the core GoodRx platform for prescription drug price comparison and discount coupons, GoodRx Gold (subscription service for enhanced savings), GoodRx Care (telehealth platform), GoodRx for Weight Loss (condition-specific subscription for GLP-1 treatments), and initiatives including RxSmartSaver and Community Link. The company does not own pharmacies or pharmaceutical manufacturers but partners with them.

Is GoodRx publicly traded?
Yes, GoodRx Holdings, Inc. is publicly traded on the Nasdaq stock exchange under ticker GDRX. The company went public in September 2020, raising approximately $1.1 billion in its IPO. GoodRx has a dual-class share structure with 108.6 million Class A shares and 234.0 million Class B shares as of February 2026. Class B shares carry ten votes per share, giving founders and early investors disproportionate voting control. The market value of non-affiliate shares was approximately $423.2 million as of June 2025.

Who is the CEO of GoodRx?
Wendy Barnes has served as President and CEO of GoodRx since January 1, 2025. She succeeded Interim CEO Scott Wagner. Barnes has over 30 years of experience in the pharmacy and medical benefit industry, including roles as CEO of RxBenefits (2022 to 2024) and President of Express Scripts Pharmacy (2019 to 2022). She holds a B.S. in Biochemistry from the United States Air Force Academy and an MBA from the University of Alaska Anchorage.

Who founded GoodRx?
GoodRx was founded in 2011 by Trevor Bezdek, Doug Hirsch, and Scott Borchert in Santa Monica, California. The founders recognized that prescription drug prices vary widely between pharmacies and built a platform to help consumers compare prices and access discount coupons. Bezdek serves as Chairman of the Board. The founders wanted to make healthcare more affordable for Americans.

Where is GoodRx headquartered?
GoodRx is headquartered in Santa Monica, California, USA. The company has been based in Santa Monica since its founding in 2011. GoodRx operates primarily in the United States, with approximately 1,000 employees. The company does not have international operations.

What is GoodRx's revenue?
GoodRx reported FY2025 revenue of $796.9 million, up 1 percent from $792.3 million in FY2024. Net income was $30.4 million, and adjusted EBITDA was $270.5 million with a 33.9 percent margin. Revenue is divided into prescription transactions ($544.0 million), pharma direct ($151.4 million, up 41 percent), and subscriptions ($83.8 million). For FY2026, GoodRx guided to revenue of $750 to $780 million, representing a 2 to 6 percent decline.

What was the FTC action against GoodRx?
In February 2023, the FTC filed an enforcement action against GoodRx for sharing users' sensitive health information with Facebook, Google, and Criteo for advertising purposes, despite promising users it would never share such data. GoodRx agreed to pay a $1.5 million civil penalty and stop sharing health data with third parties for advertising. A related class action lawsuit resulted in a revised $32 million settlement in December 2025. The FTC's action was the first enforcement under its Health Breach Notification Rule.